Sonoma Pharmaceuticals
SNOA
#11037
Rank
โ‚ฌ5 M
Marketcap
0,99ย โ‚ฌ
Share price
-6.84%
Change (1 day)
-68.25%
Change (1 year)

EPS for Sonoma Pharmaceuticals (SNOA)

EPS in 2026 (TTM): -1,40ย โ‚ฌ

According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,50ย โ‚ฌ. In 2018 the company made an earnings per share (EPS) of -356,63ย โ‚ฌ an increase over its 2017 EPS that were of -455,50ย โ‚ฌ.

EPS history for Sonoma Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,40ย โ‚ฌ
2018-356,63ย โ‚ฌ-21.7%
2017-455,50ย โ‚ฌ-241.62%
2016321,62ย โ‚ฌ-170.36%
2015-457,13ย โ‚ฌ-354.55%
2014179,59ย โ‚ฌ-122.01%
2013-815,97ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,17ย โ‚ฌ-88.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,86ย โ‚ฌ-42.42%๐Ÿ‡บ๐Ÿ‡ธ USA